Discovery2Diagnostics

*Evidence of Expanded Regulatory Activity for Animal microRNAs* Isidore Rigoutsos, Ph.D., Manager, Bioinformatics & Pattern Disc. Group, Comp. Biology Center, Deep Computing Institute, IBM Thomas J Watson Research Center	*Application of Biomarkers for Early Decision Making and Patient Selection* Scott Patterson, Ph.D., Executive Director, Medical Sciences, Amgen Inc.	*Regulation of Emerging Diagnostics* Richard Naples, Vice President, Corporate Regulatory Affairs, BD Medical - Pharmaceutical Systems	*miRNA Expression in Stem Cells* Mahendra Rao, MD, Ph.D., Vice President, Research, Stem Cells and Regenerative Medicine, Invitrogen Corporation
*Assessing Genetic Risk Factors for Common Human Diseases* Dietrich Stephan, Ph.D., Co-founder and CSO, Navigenics, Director & Senior Investigator, Neurogenomics Division, Translational Genomics Research Institute	*Global Reconstruction of the Human Metabolic Network based on Genomic and Bibliomic Data* Bernhard Palsson, Ph.D., Galetti Professor of Bioengineering and Adjunct Professor Medicine, University of California at San Diego	*Democratizing Molecular Diagnostics: the Challenge of Implementing New Technology* David Persing, MD, Ph.D., Executive Vice President, Chief Medical and Technology Officer, Cepheid	*Chips, SNPs, and Microbial Attribution* Thomas Cebula, Ph.D., Director, Office of Applied Research & Safety Assessment, CFSAN, FDA